On the other hand, in the AML-treated, but not the CYT-treated, group, the expression levels of BAX (intrinsic pathway) and FAS and CASP3 (extrinsic pathway) were significantly increased compared to the control group (Figure 4C). This evidence concerns the gene BAX and acute myeloid leukemia.